Affy Pharma
Affy Pharma Pvt Ltd is an Indian pharmaceutical and nutraceutical contract manufacturer operating three GMP-certified facilities in Baddi, producing tablets, capsules, syrups, injectables, and ointments. It serves nearly 800 clients across 6,000+ brands and provides contract manufacturing to enterprise pharma firms.
- Company typePrivate
- Founded1993
- HeadquartersNoida, India
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Affy Pharma does
Affy Pharma Pvt Ltd is an Indian pharmaceutical and nutraceutical manufacturer headquartered in Noida, Uttar Pradesh, with manufacturing operations based in Baddi, Himachal Pradesh. Founded approximately 25 years ago, the company operates three state-of-the-art manufacturing units comprising 13 specialized production sections and two dedicated packaging and printing units, producing tablets, capsules, syrups (including beta-lactam and non-beta-lactam dry syrups), injectables, and ointments at annual capacities of 2.4 billion tablets, 1 billion soft gelatin capsules, 18 million dry syrups, and 1.2 million injectable units.
The company serves two overlapping customer bases. First, it markets a proprietary portfolio of more than 6,000 brands across six therapeutic segments — Pain Management, Anti-Infectives, Paediatrics, Gynaecology, Gastrointestinal, and Beta-Lactam formulations — distributed through four specialized marketing divisions (Scala, Relivo, Allenburg, and one additional). Second, it operates a contract manufacturing business offering end-to-end services from formulation development through final packaging to enterprise pharmaceutical clients including Zydus, Intas, Astra-IDL, Elder, and Kopran, serving nearly 800 total clients domestically and internationally.
Revenue is generated through own-brand pharmaceutical and nutraceutical product sales and contract manufacturing services, with indicative unit-based pricing subject to order confirmation. Operations are supported by WHO-GMP, cGMP, and ISO 9001:2015 certifications, fully segregated beta-lactam production areas to prevent cross-contamination, and in-house quality control laboratories. The company is privately held with no disclosed external funding and is led by founder and managing director Arvind Billa. Annual turnover is approximately INR 1 Billion with a workforce of 650+ professionals.
Affy Pharma firmographics
Firmographics- Name
- Affy Pharma
- Legal name
- Affy Pharma Pvt Ltd
- Website
- https://affypharma.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Affy Pharma Pvt Ltd is an Indian pharmaceutical and nutraceutical contract manufacturer operating three GMP-certified facilities in Baddi, producing tablets, capsules, syrups, injectables, and ointments. It serves nearly 800 clients across 6,000+ brands and provides contract manufacturing to enterprise pharma firms.
- Ownership category
- akta.pro rank
Affy Pharma industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
- akta.pro secondary industries
- Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)
Keywords
Where Affy Pharma is headquartered
LocationHeadquarters
- HQ city
- Noida
- HQ country
- India
- HQ region
- Asia
Offices2 records
Markets served
Affy Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Contract Manufacturing: Third-party and contract manufacturing services providing scalable manufacturing capacity, strict quality assurance, and transparent processes. Works closely with clients to meet customized formulations, packaging, and regulatory requirements.
- Pharmaceutical Product Portfolio: Manufacturing and marketing of pharmaceutical products across key therapeutic segments including Pain Management, Anti-Infectives, Paediatrics, Gynaecology, Gastrointestinal, and Beta-Lactam formulations. Portfolio of more than 6,000 brands.
- Nutraceutical Products: Manufacturing and marketing of nutraceutical products under GMP-compliant processes with stringent quality guidelines.
- Marketing Division Revenue: Revenue generated through 4 specialized marketing divisions (Scala, Relivo, Allenburg) serving domestic and international markets.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Generic Medicines - Indicative Pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Affy Pharma product offering
Product offeringCore offering
Affy Pharma manufactures and markets pharmaceutical and nutraceutical products across multiple dosage forms including tablets, capsules, syrups, injections, and ointments, serving pharmaceutical companies across therapeutic segments such as Pain Management, Anti-Infectives, Paediatrics, Gynaecology, Gastrointestinal, and Beta-Lactam formulations. The company also offers end-to-end contract manufacturing services from formulation development to final packaging for pharmaceutical clients seeking GMP-compliant manufacturing partners.
Product overview
Affy Pharma is a GMP-certified pharmaceutical and nutraceutical manufacturer offering a diversified portfolio of more than 6,000 brands across domestic and international markets. The company operates three state-of-the-art manufacturing units with 13 specialized production sections. Their product portfolio spans multiple therapeutic segments including Pain Management, Anti-Infectives, Paediatrics, Gynaecology, Gastrointestinal, and Beta-Lactam formulations. Key dosage forms include Tablets, Capsules, Syrups (including Beta-Lactam and Non-Beta-Lactam dry syrups), Injections, and Ointments. The company also offers contract manufacturing services and operates through four specialized marketing divisions (Affy, Scala, Relivo, and Allenburg). Production capacity includes 2.4 billion tablets, 1 billion soft gelatin capsules, 18 million dry syrups, and 1.2 million injectable units annually.
Differentiator
Problem solved
Functional benefit
Brands
- Scala: Marketing division of Affy Group operating across multiple therapeutic segments
- Relivo
- Allenbug
Products and services
- Pharmaceutical Contract Manufacturing Services End-to-end contract manufacturing solutions for pharmaceutical companies covering tablets, capsules, syrups (Beta-Lactam and Non-Beta-Lactam), injections, and ointments. Services span formulation development to final packaging with scalable manufacturing capacity, strict quality assurance, transparent processes, and compliance with national and international regulatory standards.
- Nutraceutical Contract Manufacturing Services Nutraceutical manufacturing services following stringent quality guidelines under GMP-compliant processes, including vitamin and wellness supplements. Operations follow controlled environments, validated processes, and thorough quality checks ensuring consistency, stability, and safety across every batch produced.
- Pharmaceutical Tablets Branded pharmaceutical tablet products across multiple therapeutic segments including Pain Management, Anti-Infectives, Paediatrics, Gynaecology, and Gastrointestinal formulations. Branded product lines include Afexim-250, Afexim-500, Affigra, Affycon, Affydox, Affymox, Ambiflam, Azithrocord-250, Azithrocord-500, Ceficord-200 LB, Exicef-O, D-Fenac, and NP Plus. Manufactured with advanced granulation, blending, compression, and coating systems.
- Pharmaceutical Syrups and Dry Syrups GMP-compliant pharmaceutical dry syrup products including Beta-Lactam and Non-Beta-Lactam formulations for pediatric and adult use. Branded product lines include Affydox-CV DS, Affymox 125 DS, Affymox 250 DS, Affymox CV DS, Ceficord CV DS, Ceficord DS, and Cefpocord DS. Annual production capacity of 18 million units ensuring consistent quality, safety, and dosing accuracy.
- Pharmaceutical Injections Sterile injectable pharmaceutical products manufactured with aseptic processing and controlled cleanroom environments. Branded product lines include Affycet-L Injection, Affycet-T Injection, Affymore Injection, and Cefricord Injection. Annual capacity of 1.2 million injectable units with comprehensive quality testing ensuring product sterility, stability, and consistency.
- Pharmaceutical Ointments Topical pharmaceutical ointment products manufactured under strict quality and regulatory compliance. Branded product lines include Garner 4G and Garner 10G for dermatological applications.
- Nutraceutical Products Nutraceutical products manufactured under GMP-compliant processes with stringent quality guidelines. Branded product lines include Affyvit D3 for vitamin D3 supplementation and wellness products.
- Beta-Lactam Formulations (Tablets and Dry Syrups) Dedicated dosage-form-specific manufacturing for Beta-Lactam antibiotic formulations including tablets and dry syrups (penicillins and cephalosporins). Operates in fully segregated Beta-Lactam production areas to prevent cross-contamination and ensure patient safety, with controlled environments and validated equipment.
Quantifiable outcome
- Nearly 800 clients served with portfolio of more than 6,000 brands across domestic and international markets
- +2 more outcomes
Companies that use Affy Pharma
Customer profileNamed customers5 records
Segments7 records
Ideal customer profiles1 record
Affy Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Affy Pharma partnerships and signals
Strategic signalScale indicators7 records
Expansion highlights4 records
Affy Pharma competitors and assessment
Company assessmentDirect peers
- Granules India: Indian pharmaceutical manufacturer focused on finished dosage forms including tablets, capsules, and APIs with strong formulation manufacturing scale. Comparable on generic finished dosage form manufacturing with similar India-based operations.
- Akums Drugs & Pharmaceuticals: India's largest contract development and manufacturing organization (CDMO) producing tablets, capsules, injectables, ointments, and syrups. Direct comparable on contract manufacturing services, dosage forms, and Indian GMP manufacturing footprint similar to Affy.
- Mangalam Drugs & Organics: Smaller-scale Indian manufacturer of pharmaceutical finished dosage forms (tablets, capsules) and APIs. Comparable on India-based formulation manufacturing footprint though operating at smaller scale than Affy.
- Ipca Laboratories: Indian pharmaceutical manufacturer producing formulations across therapeutic segments including pain management, anti-infectives, and Beta-Lactam. Direct peer given shared therapeutic segments and Indian formulation manufacturing base.
Broad incumbents
- Aurobindo Pharma: One of India's largest generic pharmaceutical manufacturers with significant API and finished dosage form manufacturing. Comparable as an Indian-based generic pharma manufacturer, but operates at materially larger scale and with broader global reach than Affy.
- Cipla: One of India's largest pharmaceutical manufacturers with broad presence in generics, APIs, and complex generics including respiratory and anti-infectives. Comparable on Indian formulation manufacturing but operates at much greater scale and with deeper R&D investment.
- Zydus Lifesciences (formerly Cadila Healthcare): Major Indian pharmaceutical manufacturer with significant formulation and API manufacturing across multiple therapeutic segments. Functions as both an Affy customer (named contract manufacturing partner) and a much larger competitor in Indian generics.
- Intas Pharmaceuticals: Major Indian pharmaceutical company with significant formulation manufacturing across multiple therapeutic categories. Functions as both an Affy customer and a broader Indian pharma manufacturer peer at larger scale.
- Alkem Laboratories: Indian pharmaceutical manufacturer with strong presence in generics across anti-infectives, pain management, and chronic therapy segments. Comparable on Indian formulation manufacturing and therapeutic segment overlap with Affy.
Emerging players
- Emami (pharmaceutical and OTC division): Indian conglomerate with pharmaceutical and OTC healthcare product portfolio including ointments and topical formulations. Partial overlap with Affy's ointment manufacturing capability and Indian market positioning.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Affy Pharma social profiles
Digital presenceAffy Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Affy Pharma leadership team
Management profileNumber of profiles
Profiles1 record
Affy Pharma subsidiaries and ownership
Company hierarchySubsidiaries5 records
Affy Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Affy Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Affy Pharma
What does Affy Pharma do?
Affy Pharma manufactures and markets pharmaceutical and nutraceutical products across multiple dosage forms including tablets, capsules, syrups, injections, and ointments, serving pharmaceutical companies across therapeutic segments such as Pain Management, Anti-Infectives, Paediatrics, Gynaecology, Gastrointestinal, and Beta-Lactam formulations. The company also offers end-to-end contract manufacturing services from formulation development to final packaging for pharmaceutical clients seeking GMP-compliant manufacturing partners.
Is Affy Pharma a public or private company?
Affy Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Affy Pharma founded?
Affy Pharma was founded in 1993. It employs 501 to 1,000 people.
Where is Affy Pharma based?
Affy Pharma is headquartered in Noida, India, in the Asia region.
How does Affy Pharma make money?
Four revenue lines are on record. Contract Manufacturing is the primary driver. The others are pharmaceutical Product Portfolio, nutraceutical Products and marketing Division Revenue.
Who are Affy Pharma's main competitors?
Direct peers on record are Granules India, Akums Drugs & Pharmaceuticals, Mangalam Drugs & Organics and Ipca Laboratories. Broad incumbents are Aurobindo Pharma, Cipla, Zydus Lifesciences (formerly Cadila Healthcare), Intas Pharmaceuticals and Alkem Laboratories. Emami (pharmaceutical and OTC division) is listed as an emerging player.
Does Affy Pharma have an API?
No public API is recorded for Affy Pharma.
What industry is Affy Pharma in?
Affy Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of HLAIAAAN, Pain Management & Anesthesiology Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.